Sfoglia per Autore
Arginine-glycine-glutamine and serine-isoleucine-lysine-valine-alanine-valine modified poly(l-lactide) films : bioactive molecules used for surface grafting to guide cellular contractile phenotype
2014 F. Boccafoschi, L. Fusaro, M. Botta, M. Ramella, P. Chevallier, D. Mantovani, M. Cannas
Decellularized biological matrices : an interesting approach for cardiovascular tissue repair and regeneration
2015 F. Boccafoschi, M. Botta, L. Fusaro, F. Copes, M. Ramella, M. Cannas
PCSK9 expression is regulated by pro-inflammatory cytokines and adipokines in HEPG2 cells
2016 M. Botta, C. Songia, C. Macchi, N. Ferri, A. Corsini, P. Magni, M. Ruscica
High density lipoproteins inhibit oxidative stress-induced prostate cancer cell proliferation
2016 M. Ruscica, M. Botta, N. Ferri, C. Songia, G. Franceschini, L. Calabresi, P. Magni, M. Gomaraschi
Pro-inflammatory cytokines and adipokines regulate PCSK9 expression in HepG2 cells
2017 M. Ruscica, M. Botta, M. Garzone, C. Macchi, S. Marchiano, A. Corsini, P. Magni, N. Ferri
PCSK9, SINDROME METABOLICA E DIABETE
2017 N. Ferri, C. Macchi, M. Botta, S. Marchianò, C.R. Sirtori, A. Corsini, M. Ruscica
Circulating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study
2017 M. Ruscica, N. Ferri, F. Fogacci, M. Rosticci, M. Botta, S. Marchiano, P. Magni, S. D'Addato, M. Giovannini, C. Borghi, A.F.G. Cicero
Body composition and metabolic changes during a 520-day mission simulation to Mars
2018 F. Strollo, C. Macchi, I. Eberini, M.A. Masini, M. Botta, G. Vassilieva, I. Nichiporuk, M. Monici, D. Santucci, F. Celotti, P. Magni, M. Ruscica
High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell Proliferation
2018 M. Ruscica, M. Botta, N. Ferri, E. Giorgio, C. Macchi, G. Franceschini, P. Magni, L. Calabresi, M. Gomaraschi
Influence of body variables in the development of metabolic syndrome : A long term follow-up study
2018 C. Pavanello, A.M. Zanaboni, S. Gaito, M. Botta, G. Mombelli, C.R. Sirtori, M. Ruscica
PPAR Agonists and Metabolic Syndrome : An Established Role?
2018 M. Botta, M. Audano, A. Sahebkar, C. Sirtori, N. Mitro, M. Ruscica
Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disorders
2018 M. Ruscica, S. Simonelli, M. Botta, A. Ossoli, M.G. Lupo, P. Magni, A. Corsini, M. Arca, L. Pisciotta, F. Veglia, G. Franceschini, N. Ferri, L. Calabresi
From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in cardiovascular disease patients
2018 M.G. Zenti, A. Altomari, M.G. Lupo, M. Botta, E. Bonora, A. Corsini, M. Ruscica, N. Ferri
PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor
2019 L. Da Dalt, M. Ruscica, F. Bonacina, G. Balzarotti, A. Dhyani, E. Di Cairano, A. Baragetti, L. Arnaboldi, S. De Metrio, F. Pellegatta, L. Grigore, M. Botta, C. Macchi, P. Uboldi, C. Perego, A.L. Catapano, G.D. Norata
Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract : results from a randomized, double-blind, placebo-controlled study
2019 M. Ruscica, C. Pavanello, S. Gandini, C. Macchi, M. Botta, D. Dall’Orto, M. Del Puppo, M. Bertolotti, R. Bosisio, G. Mombelli, C.R. Sirtori, L. Calabresi, P. Magni
Deciphering the role of V200A and N291S mutations leading to LPL deficiency
2019 M. Botta, E. Maurer, M. Ruscica, S. Romeo, T.M. Stulnig, P. Pingitore
DECIPHERING THE ROLE OF ADIPOKINES ON PCSK9 REGULATION: EXPERIMENTAL EVIDENCE
2019 M. Botta
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile